| Business Summary |
| A biopharmaceutical company, dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. |
| General Information |
7000 Shoreline Ct.,
Suite 370
South San Francisc, CA 94080
|
| www.hanabiosciences.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 33 |
| CEO: Dr. Steven R. Deitcher, |
| Short Interest |
| Current Month (Mil) |
0.26 |
| Previous Month (Mil) |
0.05 |
| Short Interest Ratio (Days) |
4.40 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-515.40 |
| Return on Investments |
1,115.00 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet